Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma

Archives of Ophthalmology

Volumn 126, Issue 1, 2008, Pages 137-139

  Phillips, Paul M ^a   Newman, Steven A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; ZOLEDRONIC ACID;

ADULT; ARTICLE; BONE METASTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EYE EDEMA; EYE FUNDUS; EYE MOVEMENT; EYE PAIN; FEVER; HUMAN; KIDNEY CARCINOMA; MALE; ORBIT INFLAMMATION; PRIORITY JOURNAL; VISUAL ACUITY;

ADMINISTRATION, ORAL; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; CARCINOMA, RENAL CELL; DIPHOSPHONATES; GLUCOCORTICOIDS; GRANULOMA, PLASMA CELL, ORBITAL; HUMANS; IMIDAZOLES; INFUSIONS, INTRAVENOUS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PREDNISONE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38349049482     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archophthalmol.2007.17     Document Type: Article

References (4)

1. Macarol V, Fraunfelder FT. Pamidronate disodium and possible ocular adverse drug reactions. Am J Ophthalmol. 1994;118(2):220-224.
2. Ryan PJ, Sampath R. Idiopathic orbital inflammation following intravenous pamidronate. Rheumatology (Oxford). 2001;40(8):956-957.
3. Subramanian PS, Kerrison JB, Calvert PC, Miller NR. Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer. Arch Ophthalmol. 2003;121(9):1335-1336.
4. Fraunfelder FW, Fraunfelder FT. Bisphosphonates and ocular inflammation. N Engl J Med. 2003;348(12):1187-1188.